Unclaimed brand
- Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD) NORTH...
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#4D81FF
Dodger Blue
77, 129, 255
222, 100, 65
70, 49, 0, 0
#EFC99B
Chalky
239, 201, 155
33, 72, 77
0, 16, 35, 6
#212121
Mine Shaft
33, 33, 33
0, 0, 13
0, 0, 0, 87
Landos Biopharma is a clinical stage biopharmaceutical company that is dedicated to developing innovative, oral therapeutics for patients with autoimmune diseases. Their mission is to provide safer and more effective treatments that fill the therapeutic gaps in the current treatment options. As a highly productive research engine, Landos focuses on two novel targets anchored in libraries of immunometabolic modulation pathways.
They have developed four potentially first-in-class, once-daily, oral therapies that target eight indications in the field of immunology. One of their lead product candidates is NX-13, which targets the NLRX1 pathway. This oral therapy is gut-selective and orally-active, allowing for targeted engagement within the gastrointestinal tract.
In a recent Phase 1b trial, NX-13 demonstrated a favorable safety and tolerability profile in patients with Ulcerative Colitis (UC), as well as promising early signals of clinical improvement in symptoms and endoscopy results. Landos is now focused on advancing the clinical development of NX-13 in UC. They have initiated the NEXUS Phase 2 proof-of-concept trial and expect to report topline results by the fourth quarter of 2024.
With a dedicated and experienced team, Landos Biopharma is committed to making a positive impact on the lives of patients with autoimmune diseases
Inflammatory bowel disease therapeutics
Oral NLRX1 agonists
Ulcerative colitis drug development
Crohn's disease drug development
Immunometabolism research
How do I download the AbbVie logo?
The AbbVie logo comes in two versions: a logo and an icon. Download as SVG, transparent PNG or JPEG.
What does AbbVie's branding look like?
The Landos Biopharma wordmark is a distinctive lowercase “abbvie” logo in a wide, rounded black custom letterform, with no separate emblem. Its visual identity is restrained and clinical, pairing clean typography with a white canvas, dark text, and sparse blue links; communications favor straightforward layouts and scientific or corporate content over decorative imagery.
What are AbbVie's brand colors?
The AbbVie color palette uses the hex codes #4D81FF, #EFC99B and #212121.
The AbbVie name, logos and brand assets are trademarks of AbbVie and its affiliates. Brandfetch isn't affiliated with or endorsed by AbbVie. Their use is subject to AbbVie's brand guidelines.
